baber/WOPTO huggingface dataset:
Patent AU-2001280515-B2 (AU)
Title: Medical valve with positive flow characteristics
Inventor: FANGROW THOMAS F JR
IPC: A61M39/04
Filed: 2001-07-11
Granted: 2007-01-25
Abstract: A valve (20) for selectively permitting a fluid flow between first (22) and second (24) medical implements is disclosed. The valve has a housing (30) with an interface (34) suitable for receiving a connector portion of a first medical device such as a catheter, and a seal (32) made of a flexible material. The seal has a first end in fluid communication with the interface, a second end suitable for receiving the second medical device, and at least one slit (38) in fluid communication with the first end and the second end. The slit defines a restricted fluid flow path and a relatively small interior volume when in an undisturbed state, defines an expanded fluid flow path and a larger interior volume upon the introduction of the second medical instrument into the slit, and retracts to define a restricted flow path and a small interior volume upon the withdrawal of the second medical device from the seal.
Patent AU-2002215958-B2 (AU)
Title: Use of inhibitors of progesterone receptor for treating cancer
Inventor: FUHRMANN ULRIKE
IPC: A61K31/567
Filed: 2001-10-17
Granted: 2006-08-17
Abstract: The invention relates to the use of progesterone receptor inhibitors for inhibition of growth-factor-dependency of tumor cells.
Patent AU-2002235503-B2 (AU)
Title: Constricted neck blister pack and apparatus and method for making the same
Inventor: HEATH KENNETH
IPC: B65D75/36
Filed: 2002-02-01
Granted: 2006-04-27
Abstract: The invention herein provides for a blister pack which confines the movement a dosage form in order to resist damage thereto during handling and transportation while permitting removal of the intact dosage form, and apparatus and methods for the same. In particular, the invention provides a blister pack wherein the blister includes a protruding region between the opening and the base, thereby producing a constricted area or "neck" in the blister. In a preferred embodiment, the protruding region comprises an inwardly directed annulus formed in the blister wall. Accordingly, vertical movement of the dosage form is confined as a result of the protruding region, thereby reducing the likelihood of damage to the dosage form caused by agitation of the blister pack. The invention is particularly useful in packaging frangible pharmaceutical dosage forms formed in situ within in the blister, such as freeze dried dosage forms and rapidly dissolving oral dosage forms.
Patent AU-2002243411-B2 (AU)
Title: Combination of an estrogen and an androgen for treating hormonal deficiencies in women undergoing estrogen replacement therapy
Inventor: WALDON R FORREST
IPC: A61P19/10
Filed: 2001-12-21
Granted: 2007-02-08
Abstract: The present invention combines the administration of estrogens with the administration of non-aromatizing androgens to treat hormonal deficiencies in women undergoing estrogen replacement therapy.
Patent AU-2002303239-B2 (AU)
Title: Transdermal electrotransport delivery device including an antimicrobial compatible reservoir composition
Inventor: CORMIER MICHEL J N
IPC: A61N1/30
Filed: 2002-04-04
Granted: 2006-03-16
Abstract: A transdermal electrotransport drug delivery device having an anode, a cathode and a source of electrical power electrically connected to the anode and the cathode. At least one of the anode and the cathode includes an electrode and a reservoir comprised of a housing composed of a polymeric material and an aqueous medium in contact with the housing. The aqueous medium includes (i) a drug or an electrolyte salt or a mixture thereof, (ii) propylene glycol, and (iii) an antimicrobial agent in an amount sufficient to inhibit microbial growth in the aqueous medium. The propylene glycol prevents the antimicrobial agent from being adsorbed by other materials used in the construction of the delivery device. A process for preparing a transdermal electrotransport drug delivery device is also provided.
Patent AU-2002340570-B2 (AU)
Title: Desiccant mass, method for obtaining same and use thereof
Inventor: BLONDEL JEAN-MARIE
IPC: B01D53/28
Filed: 2002-10-16
Granted: 2008-03-06
Abstract: The invention concerns a desiccant mass comprising a mixture of loose fibers and at least an alkali or an alkaline-earth metal halide and optionally at least a calcic compound different from the alkali or alkaline-earth metal halide. The invention also concerns a method for making such a desiccant mass, which consists in mixing the loose fibers with at least an alkali or alkaline-earth metal halide and, optionally, with at least a calcic compound, in the presence of sufficient amount of water to obtain an extrusible mass, then in extruding said extrusible mass and in drying the extruded mass. The invention further concerns the use of said desiccant mass in particular for dehydrating and controlling moisture.
Patent AU-2003273206-B2 (AU)
Title: Method, composition and kit for antigenic binding of Norwalk-Like viruses
Inventor: PENDU JACQUES LE
IPC: A61K31/70
Filed: 2003-06-02
Granted: 2009-08-20
Abstract: A method for preventing or treating an active Norwalk-Like Virus (NLV) infection in the gastrointestinal (GI) tract of a host, comprising the step of administering orally a fucosyl α1→2 carbohydrate compound to the host, the compound having a binding specificity of the antigenic determinant of a human histo-blood group antigen and competitively binds with a NLV at the determinant binding site of the NLV. The compound inhibits binding of the NLV in vivo to a histo-blood group antigen of the host, thereby inhibiting the active infection or preventing infection of the GI tract of the host by the NLV.
Patent AU-2003297557-B2 (AU)
Title: Methods for using primers that encode one strand of a double-stranded promoter
Inventor: JENDRISAK JEROME J
IPC: C12P19/34
Filed: 2003-11-21
Granted: 2009-02-26
Abstract: The present invention provides methods, compositions and kits for using an RNA polymerase for making transcription products corresponding to a target sequence by obtaining circular single-stranded DNA transcription substrates using a promoter primer that encodes one strand of a double-stranded promoter. The invention has broad applicability for research, diagnostic and therapeutic applications, such as preparing cDNA corresponding to mRNA, making sense or anti-sense probes, detecting gene- or organism-specific sequences, or making RNAi.
Patent AU-2004207504-B2 (AU)
Title: System and method for treating fly ash
Inventor: MAJORS RUSS K
IPC: C04B18/08
Filed: 2004-01-22
Granted: 2008-06-19
Abstract: A method and system for treating fly ash with a treating fluid by evenly dispersing a treating fluid into a flowing stream of fly ash. By dispersing the treating fluid into the fly ash as the fly ash is flowing, the method takes advantage of natural mixing and particle motion that occurs during flow of the bulk solid. The application of treating fluid is advantageously controlled by an automated controller that has inputs and outputs that allow the controller to adjust flow rate of the treating fluid in correspondence with a measured flow rate of the fly ash.
Patent AU-2004222822-B2 (AU)
Title: A factor VIII-polypeptide with factor VIII:C-activity
Inventor: SCHEIFLINGER FRIEDRICH
IPC: C07K14/755
Filed: 2004-10-22
Granted: 2007-01-25
Abstract: Factor VIII polypeptides having FVIII:C activity that contain modifications in the A3 and/or C1 and/or C2 domains of the sequence of the light chain of Factor VIII, characterized by the binding affinity to low density lipoprotein receptor protein, and methods for producing the same.
Patent AU-2004236208-B2 (AU)
Title: Selective R-cadherin antagonists and methods
Inventor: DORRELL MICHAEL I
IPC: A61K38/08
Filed: 2004-04-30
Granted: 2009-10-29
Abstract: An isolated peptide useful as a selective antagonist of mammalian R-cadherin comprises 3 to 30 amino acid residues, three contiguous residues of the peptide having the amino acid sequence Ile-Xaa-Ser; wherein Xaa is an amino acid residue selected from the group consisting of Asp, Asn, Glu, and Gln. Preferably Xaa is Asp or Asn. In one preferred embodiment the peptide is a cyclic peptide having 3 to 10 amino acid residues arranged in a ring. The selective R-cadherin antagonist peptides of the invention are useful for inhibiting the targeting of stem cells, such as endothelial precursor cells, to developing vasculature, for inhibiting R-cadherin mediated cellular adhesion, and for inhibiting retinal angiogenesis.
Patent AU-2004237413-B2 (AU)
Title: Freshly prepared extruded fat-based confectionery product with temporary flexibility having enhanced melt-in-the-mouth properties and method of dispensing the same
Inventor: OVAICI HOOMAN
IPC: A23G3/20
Filed: 2004-05-06
Granted: 2011-01-27
Abstract: The invention relates to an apparatus adapted to deliver a fat based confectionery product on demand, in a foodservice or household environment, which exhibits play value and enhanced decorative attributes. The apparatus of the invention comprises barrel means for receiving a predetermined amount of fat based confectionery material, a pressure engaging means for engaging under pressure the fat based confectionery material contained in the barrel means. The apparatus further comprises die means arranged for producing at least one elongated strand of the fat based confectionery product of a surface-area-to-mass ratio that is higher than 8.0 cm2 per gram unit, and control means for actuating the pressure engaging means with the barrel means upon the push of a button and for extruding the at least one strand of the fat based confectionery.
Patent AU-2005244578-B2 (AU)
Title: Reinforced cementitious material product and method of manufacture of the same
Inventor: MOREY PHILIP
IPC: E04C5/06
Filed: 2005-12-16
Granted: 2012-03-15
Abstract: A reinforced cementitious material product, including a reinforcement structure 10 extending in three dimensions within the product. [Figure 1] yI ISO, is0
Patent AU-2005316384-B2 (AU)
Title: RNAi modulation of MLL-AF4 and uses thereof
Inventor: HADWIGER PHILIPP
IPC: C07H21/04
Filed: 2005-12-14
Granted: 2012-02-09
Abstract: The invention relates to compositions and methods for modulating the expression of the MLL-AF4 fusion gene, and more particularly to the downregulation of MLL-AF4 by chemically modified oligonucleotides.
Patent AU-2006230810-B2 (AU)
Title: Improvements in control of heat exchangers
Inventor: PAUL BAKER BENJAMIN
IPC: F28D17/00
Filed: 2006-04-06
Granted: 2011-06-23
Abstract: A heat exchanger (10) has an outer housing (16) and a first helical fluid flow path or coil (12) located in the housing (16) defining a plurality of turns and having an inlet (24) and an outlet (22) for entry and exit of fluid into the flow path to be heated or cooled. A second helical coil (14) defining a second fluid flow path is located within the housing (16) adjacent to the first coil. The second coil also has an inlet (24) and outlet (22) for a passage for hot or cold service media. A conductive or non-conductive sheath (18) is disposed between the coils. A transfer medium is disposed in the housing for transfer of heat between the first and second flow paths. A plurality of baffles (20) are located between the outer housing and sheath and disposed between turns of the first coil. A plurality of baffles (21) are also disposed between turns of the second coil (14). By interposing a transfer medium between the two fluid flow paths rather than having one of the fluid flows as the medium itself, control over the cooling or heating of the fluid to be heated or cooled is possible. The fluid being cooled or heated and fluid transfer medium may be at different temperatures. The sheath (18) and baffles (20, 21) help control the transfer of heat and improve the efficiency of the heat exchanger.
Patent AU-2006239721-B2 (AU)
Title: Production of recombinant proteins by autoproteolytic cleavage of a fusion protein
Inventor: BERNHARD AUER
IPC: C12N15/62
Filed: 2006-04-25
Granted: 2011-07-14
Abstract: The invention relates to a process for the recombinant production of a heterologous polypeptide of interest, comprising, (i) cultivation of a bacterial host cell which is transformed with an expression vector which comprises a nucleic acid molecule which codes for a fusion polypeptide, the fusion polypeptide comprising a derivative of an autoprotease N of Pestivirus, wherein at least one cysteine residue of the naturally occuring autoprotease N of Pestivirus is replaced by another amino acid residue, and a second polypeptide which is connected to the first polypeptide at the C-terminus of the first polypeptide in a manner such, that the second polypeptide is capable of being cleaved from the fusion polypeptide by the autoproteolytic activity of the first polypeptide, said second polypeptide being a heterologous polypeptide, wherein cultivation occurs under conditions which cause expression of the fusion polypeptide and formation of corresponding cytoplasmic inclusion bodies, (ii) isolation of the inclusion bodies from the host cell, (iii) solubilization of the isolated inclusion bodies, (iv) induction of autoproteolytic cleavage of the heterologous polypeptide of interest from the fusion polypeptide, and (v) isolation of the cleaved heterologous polypeptide of interest.
Patent AU-2006246449-B2 (AU)
Title: Vectorable nozzle with pivotable triangular panels
Inventor: TOFFAN MICHAEL JAY
IPC: F02C7/00
Filed: 2006-11-29
Granted: 2013-05-02
Abstract: VECTORABLE NOZZLE WITH PIVOTABLE TRIANGULAR PANELS A vectorable nozzle (12) includes convergent and divergent sections (14 and 16) and a throat (18) therebetween. Heightwise spaced apart upper and lower walls 5 (30 and 32) outwardly bound a nozzle flowpath (40) and extend aftwardly through the convergent and divergent sections (14 and 16) from the nozzle inlet (19) to the nozzle outlet (20). The upper wall (30) includes triangular left and right side convergent upper panels (26 and 28) pivotably mounted to a triangular convergent upper ramp (23) in the convergent section (14) along left and right side convergent angled hinge LO lines (27 and 29) respectively. The upper wall (30) further includes triangular left and right side divergent upper panels (36 and 38) pivotably attached to a triangular divergent upper ramp (35) in the divergent section (16) along left and right side divergent angled hinge lines (37 and 39) respectively. The left and right side convergent upper panels (26 and 28) are in sealing engagement with the left and right L5 side divergent upper panels (36 and 38) along left and right side upper interfaces (60 and 62), respectively.
Patent AU-2006286348-B2 (AU)
Title: Pyrrolopyridine derivatives and use of same as PPAR receptor modulators
Inventor: POUPARDIN-OLIVIER OLIVIA
IPC: A61K31/437
Filed: 2006-08-31
Granted: 2012-04-26
Abstract: The invention relates to pyrrolopyridine derivative compounds having general formula (I) as defined in the claims and to the pharmaceutically-acceptable addition salts thereof. The invention also relates to the method of preparing the aforementioned compounds, to pharmaceutical compositions containing same and to the use thereof as a pharmacologically-active substance, for example in the treatment of hypertriglyceridaemias, hyperlipidemias, hypercholesterolemias, diabetes, endothelial dysfunction, cardiovascular and inflammatory diseases and neurodegeneration.
Patent AU-2006344060-B2 (AU)
Title: Mounting system and method for enhancing implant fixation to bone
Inventor: ANGIBAUD LAURENT
IPC: A61F2/38
Filed: 2006-11-07
Granted: 2013-05-23
Abstract: The present invention relates to a mounting system and method for enhancing implant fixation to bone. That is, the present invention relates generally to the field of orthopaedics. Various embodiments of the present invention relate to the replacement (totally or partially) of a joint. In one example (which example is intended to be illustrative and not restrictive), the present invention provides a modular system with different anchoring mechanisms for optimized fixation of a joint implant to the bone (wherein "optimized" fixation may be as desired by a surgeon).
Patent AU-2007201945-B2 (AU)
Title: I.S. Machine
Inventor: SIMON JONATHAN S
IPC: C03B9/16
Filed: 2007-05-01
Granted: 2012-05-17
Abstract: An 1. S. Machine is provided wherein the blow molds are closed to a slightly cracked location whereby applied cooling air can not leak into and pressurize the 5 blow mold thereby damaging the parison during reheat. When reheat is completed, the blow molds are fully closed and the parison is transformed into a bottle by applying compressed air and/or vacuum.
Patent AU-2007225044-B2 (AU)
Title: Treatment of paroxysmal nocturnal hemoglobinuria patients by an inhibitor of complement
Inventor: BELL LEONARD
IPC: A61K38/00
Filed: 2007-03-15
Granted: 2013-03-07
Abstract: Eculizumab, a humanized monoclonal antibody against C5 that inhibits terminal complement activation, showed activity in a preliminary 12-week open-label trial in a small cohort of patients with paroxysmal nocturnal hemoglobinuria (PNH). The present study examined whether chronic eculizumab therapy could reduce intravascular hemolysis, stabilize hemoglobin levels, reduce transfusion requirements, and improve quality of life in a double-blind, randomized, placebo-controlled, multi-center global Phase III trial. It has been found that eculizumab stabilized hemoglobin levels, decreased the need for transfusions, and improved quality of life in PNH patients via reduced intravascular hemolysis. Chronic eculizumab treatment appears to be a safe and effective therapy for PNH.
Patent AU-2007238116-B2 (AU)
Title: Credit data processing system for controlling electronic trading based on credit arrangements
Inventor: KAREN SETZ
IPC: G06Q40/00
Filed: 2007-04-11
Granted: 2011-09-08
Abstract: A credit data processing system for controlling trades in an electronic trading system according to credit arrangements, comprising a computer-readable storage medium, an interface to an electronic trading system and a credit data processor. The computer-readable storage medium stores information representing the credit relationship network, including a plurality of credit entities in the network and a plurality of credit relationships existing between at least some of those credit entities. The system uses preferred counterparty rankings provided by the participating credit entities to determine and select the optimal credit paths to use for booking multiple-legged trades between credit entities even though the credit entities may not have a direct credit relationship. The system then checks each leg of the selected optimal credit path to verify that, taking into account the current net open positions on that leg, executing the trade required on that leg to carry out the proposed deal will not cause a credit limit associated with that leg to be exceeded. If the credit limit of any leg in the selected optimal credit path is exceeded, then the system will repeatedly try to find viable credit path based on the preferences specified by the credit entities involved in the trade, until a viable credit path is found or it is determined that no credit path that can accommodate the proposed deal without exceeding a credit limit currently exists.
Patent AU-2007253060-B2 (AU)
Title: A composite material
Inventor: SKERTCHLY DAVID EDWARD
IPC: C08J5/00
Filed: 2007-05-24
Granted: 2009-01-08
Abstract: A composite material comprises a layer of fibres conjoined to a matrix, where one of the matrix and fibres comprises a first component which exhibits auxetic behaviour for loading along a first direction, and the other of the matrix and fibres comprises a second component which exhibits non-auxetic behaviour for loading along the first direction.
Patent AU-2007257105-B2 (AU)
Title: Elisa kit for detecting Sudan red and method thereof
Inventor: ZHENGMIAO ZHAO
IPC: G01N33/543
Filed: 2007-05-10
Granted: 2011-06-23
Abstract: An ELISA kit for detecting Sudan red includes: a plate coated with a coating molecule, enzyme labeled molecule, Sudan red standard solution, substrate and color developing solution, stop solution, concentrated washing solution and concentrated diluting solution. The kit can also include: specific antibody concentrated solution to Sudan red and diluting solution for concentrated antibody. A detecting method for Sudan red with said ELISA kit, which includes the steps: firstly, pretreating samples; then detecting the samples with the kit; lastly, analyzing the results.
Patent AU-2007282370-B2 (AU)
Title: Process for producing flavor enhancer for beer and beer-like beverage and beverage of a roast material
Inventor: NOZAKI OSAMU
IPC: A23L27/00
Filed: 2007-08-09
Granted: 2012-05-17
Abstract: The present invention relates to a process for producing a flavor enhancer for beer and beer-like beverage and beverage of a roast material, which includes (1) heating a grinded matter of a cereal, (2) treating the grinded matter with protease, and (3) recovering an extract; and a flavor enhancer for beer and beer-like beverage and beverage of a roast material obtainable by the process. The flavor enhancer of the invention can be used for enhancing the full body and enhancement of beer and beer-like beverage and beverage of a roast material.
Patent AU-2007283819-B2 (AU)
Title: Insecticidal isoxazolines
Inventor: SHIMOJO EIICHI
IPC: A01N43/80
Filed: 2007-08-01
Granted: 2013-09-12
Abstract: Novel isoxazolines of the formula (I) wherein A represents C or N; R represents haloalkyl; X represents halogen or haloalkyl; 1 represents 0, 1 or 2; Y represents halogen, alkyl, alkoxy, haloalkyl, cyano, nitro, amino, acylamino, alkoxycarbonylamino, haloalkoxycarbonyl-amino or alkylsulfonylamino; m represents 0, 1 or 2; and G represents any one selected from heterocyclic groups described in the specification; and a use thereof as insecticides and for controlling animal parasites.
Patent AU-2007286643-B2 (AU)
Title: Cold formed cereal bar fortified with omega-3 fatty acids and processes for making same
Inventor: TURPIN JANA
IPC: A23L35/00
Filed: 2007-08-23
Granted: 2012-03-22
Abstract: Disclosed is a cold formed bar comprising an omega-3 fatty acid and a carrier oil having an oxidative stability of at least 30 hours and a solid fat content at 21° C of at least 40. The bar is preferably enrobed in a compound coating and has a water activity of from 0.45 to 0.57. The combination of carrier oil, low temperature processing, low water activity and enrobing stabilizes the omega-3 fatty acids in the bar so that the bar is stable at 85° F 50% relative humidity for at least 3 months without developing fishy aromas, fishy tastes, or other off tastes over the storage period.
Patent AU-2007295888-B2 (AU)
Title: Vitamin D compositions and method of administration to a human being
Inventor: VIETH REINHOLD W
IPC: A23L33/15
Filed: 2007-05-14
Granted: 2012-07-12
Abstract: Composition of vitamin D in medium-chain triglycerides and use thereof in delivering a nutritional or therapeutic amount of vitamin D to a human being, particularly, an infant. The compositions are applied to an object, such as skin or in the case of an infant to a woman's nipple or pacifier from which the infant sucks off the composition. The method provides a more suitable, safer and efficient way of providing the human being with vitamin D. The compositions further comprise a free fatty acid and/or monoglyceride, oxidant preservative and, optionally, other vitamins.
Patent AU-2007313160-B2 (AU)
Title: Drug-delivery endovascular stent and method of use
Inventor: FARIABI SEPEHR
IPC: A61L31/02
Filed: 2007-10-19
Granted: 2012-06-28
Abstract: A radially expandable, endovascular stent designed for placement at a site of vascular injury, for inhibiting restenosis at the site, a method of using, and a method of making the stent. The stent includes a radially expandable body formed of one or more metallic filaments where at least one surface of the filaments has a roughened or abraded surface. The stent may include a therapeutic agent on the abraded surface.